🚀 ProPicks AI Hits +34.9% Return!Read Now

PRESS DIGEST- Financial Times - Dec 1

Published 2016-11-30, 08:26 p/m
© Reuters.  PRESS DIGEST- Financial Times - Dec 1
PTNL
-
BX
-
BHC
-
4502
-
BPOST
-

Dec 1 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.

Headlines

Bpost sweetens bid in final offer for Dutch rival PostNL

http://on.ft.com/2gzMXTw

Valeant's talks to sell Salix unit for $10 bln break down

http://on.ft.com/2gMqeCP

Blackstone (NYSE:BX) to pursue IPO route for home leasing unit

http://on.ft.com/2gmF8Tn

Overview

Belgian postal company Bpost SA BPOST.BR said it made a final offer for Dutch rival PostNL NV PTNL.AS , sweetening the cash component of the bid by 0.376 euro to 3.201 euros per share, valuing the bid at about 2.54 billion euros in cash and stock.

Takeda Pharmaceutical Co Ltd's 4502.T negotiations to acquire Valeant Pharmaceuticals (NYSE:VRX) International Inc's VRX.TO Salix stomach-drug business have stalled over price disagreements, people familiar with the matter said on Wednesday.

Invitation Homes LP, the U.S. rental homes manager owned by private equity firm Blackstone Group LP BX.N , has confidentially filed for an initial public offering that could come as soon as January and raise as much as $1.5 billion, according to a source familiar with the matter.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.